We restore endothelial cell function.
Pantherna Therapeutics is a privately-held biopharmaceutical Company developing first-in-class therapeutics for vascular diseases. Pantherna’s innovative technology platform is based on advanced nanoparticles for the delivery and expression of therapeutic mRNA drugs in the endothelium.
Pantherna is based in Hennigsdorf (Brandenburg) close to Berlin, Germany.
Dr. Klaus Giese (CEO) will present in the Start-Up Slam at the BIO-Europe 2019 conference in Hamburg on Tuesday, Nov 12.
Get in touch
Pantherna Therapeutics GmbH
Telephone: +49(0)3302-202 240-0
Telefax: +49(0)3302-202 240-1
Managing Directors: Dr. Klaus Giese, Dr. Jörg Kaufmann, Dr. Gerrit Maass